Your browser doesn't support javascript.
loading
HIV Controllers Exhibit Enhanced Frequencies of Major Histocompatibility Complex Class II Tetramer+ Gag-Specific CD4+ T Cells in Chronic Clade C HIV-1 Infection.
Laher, Faatima; Ranasinghe, Srinika; Porichis, Filippos; Mewalal, Nikoshia; Pretorius, Karyn; Ismail, Nasreen; Buus, Søren; Stryhn, Anette; Carrington, Mary; Walker, Bruce D; Ndung'u, Thumbi; Ndhlovu, Zaza M.
Afiliación
  • Laher F; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
  • Ranasinghe S; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, Massachusetts, USA.
  • Porichis F; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research Institute, La Jolla, California, USA.
  • Mewalal N; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, Massachusetts, USA.
  • Pretorius K; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research Institute, La Jolla, California, USA.
  • Ismail N; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
  • Buus S; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
  • Stryhn A; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
  • Carrington M; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen N, Denmark.
  • Walker BD; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen N, Denmark.
  • Ndung'u T; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, Massachusetts, USA.
  • Ndhlovu ZM; Cancer and Inflammation Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
J Virol ; 91(7)2017 04 01.
Article en En | MEDLINE | ID: mdl-28077659
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Linfocitos T CD4-Positivos / Antígenos de Histocompatibilidad Clase II / Infecciones por VIH / VIH-1 / Productos del Gen gag del Virus de la Inmunodeficiencia Humana Límite: Female / Humans / Male Idioma: En Revista: J Virol Año: 2017 Tipo del documento: Article País de afiliación: Sudáfrica
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Linfocitos T CD4-Positivos / Antígenos de Histocompatibilidad Clase II / Infecciones por VIH / VIH-1 / Productos del Gen gag del Virus de la Inmunodeficiencia Humana Límite: Female / Humans / Male Idioma: En Revista: J Virol Año: 2017 Tipo del documento: Article País de afiliación: Sudáfrica